Fennec Pharmaceuticals (FENC) EPS (Diluted) Growth (3y) (2013 - 2025)
Fennec Pharmaceuticals (FENC) EPS (Diluted) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 13.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.63% |
| Sep 30, 2025 | 58.31% |
| Jun 30, 2025 | 16.24% |
| Mar 31, 2025 | 32.65% |
| Dec 31, 2024 | 93.05% |
| Sep 30, 2024 | -8.79% |
| Jun 30, 2024 | -9.84% |
| Mar 31, 2024 | 61.32% |
| Dec 31, 2023 | 95.92% |
| Sep 30, 2023 | 33.66% |
| Jun 30, 2023 | 0.52% |
| Mar 31, 2023 | -5.52% |
| Dec 31, 2022 | 45.32% |
| Sep 30, 2022 | -50.68% |
| Jun 30, 2022 | 6.36% |
| Mar 31, 2022 | -1.69% |
| Dec 31, 2021 | -374.54% |
| Sep 30, 2021 | -3.82% |
| Jun 30, 2021 | -3.00% |
| Mar 31, 2021 | -26.19% |